Kelvin has extensive experience in advanced biotechnology & operational strategy. He has been involved in multiple international M&A projects and global integrations including the US$700 million acquisition of Next-Gen sequencer company Ion Torrent. He holds a M. Phil. Degree in Molecular Biology from the University of Hong Kong and a MBA degree from Anderson School of Business UCLA with focus in Operational Strategy & Advanced International Management (AIM).This background has given him extensive experience in pre-clinical project management and transition from prototype commercialization through product launch. Kelvin has in-depth knowledge of business models and cultures in APAC.